Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alejandro Salinas-Illarena
Observed name:
A Salinas-Illarena
Institutions:
Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie,
Ludwig-Maximilians-Universität München
Observed institutions:
Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie,
Ludwig-Maximilians-Universität München
ORCID:
0000-0002-1315-9446
Observed ORCID:
0000-0002-1315-9446
OpenAlex ID:
A5024429317
New strategies to treat AML: novel insights into AML survival pathways and combination therapies
2020
·
Ramya Nair
, Alejandro Salinas-Illarena
, et al.
·
Leukemia
·
93
Purified recombinant lentiviral Vpx proteins maintain their SAMHD1 degradation efficiency in resting CD4+ T cells
2023
·
Ramya Nair
, Yanis Pignot
, et al.
·
Analytical Biochemistry
·
5
Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia
2024
·
Ramya Nair
, Alejandro Salinas-Illarena
, et al.
·
Clinical and Experimental Medicine
·
3
PDF
P-03.01 Generation and characterization of recombinant Vpx coupled to cell penetrating peptides
2025
·
S Aidin
, A Salinas-Illarena
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
P08.05 Lentiviral protein Vpx delivery systems as potential weapons to improve cytarabine treatment response against acute myeloid leukemia
2022
·
R Nair
, M Sponheimer
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
5
Citation count:
101
H-index:
3
I10-index:
1
Year
Topic
Type